Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Autoimmune nodopathy (AN) is caused by autoantibodies targeting the nodes of Ranvier or paranodes. AN frequently affects cranial nerves and spinal nerve roots and may accompany central demyelination, all of which belong to the intrathecal compartment. We aimed to ascertain the frequency of intrathecal antibody synthesis and blood-CSF barrier (BCSFB) dysfunction in AN and their clinical correlates.

Methods: We analyzed paired cerebrospinal fluid (CSF) and serum samples from 110 patients with AN, chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), and Guillain-Barré syndrome (GBS). BCSFB dysfunction and intrathecal total IgG synthesis were assessed using Q, Q, and IgG index. Flow cytometry was used to evaluate intrathecal autoantibody synthesis.

Results: Compared to CIDP and GBS, AN patients more frequently exhibited BCSFB dysfunction (87.5%) and intrathecal total IgG synthesis (68.8%). Among AN patients with cranial nerve or brain involvement (8/16, 50%), all had either an elevated IgG index (n = 7) or CSF-specific oligoclonal bands (n = 1). Intrathecal autoantibody synthesis was confirmed in 2 patients. Notably, both patients initially presented with cranial neuropathies. No CSF-restricted AN autoantibodies were found in the 39 seronegative CIDP and GBS patients.

Conclusions: AN exhibits distinct immunopathogenesis compared to CIDP and GBS. Intrathecal synthesis of total IgG is associated with cranial nerve or central nervous system involvement, while that of AN-specific autoantibodies relates to cranial nerve onset diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399800PMC
http://dx.doi.org/10.1111/jns.70057DOI Listing

Publication Analysis

Top Keywords

bcsfb dysfunction
12
total igg
12
cidp gbs
12
cranial nerve
12
intrathecal
8
intrathecal antibody
8
antibody synthesis
8
autoimmune nodopathy
8
intrathecal total
8
igg synthesis
8

Similar Publications

Background: Autoimmune nodopathy (AN) is caused by autoantibodies targeting the nodes of Ranvier or paranodes. AN frequently affects cranial nerves and spinal nerve roots and may accompany central demyelination, all of which belong to the intrathecal compartment. We aimed to ascertain the frequency of intrathecal antibody synthesis and blood-CSF barrier (BCSFB) dysfunction in AN and their clinical correlates.

View Article and Find Full Text PDF

Healthy neurodevelopment requires adequate folates (vitamin B9), which are critical for key biosynthetic and homeostatic processes in the central nervous system (CNS). In the brain, folate transport is mediated by three major pathways: folate receptor alpha (FRα), proton-coupled folate transporter (PCFT), and reduced folate carrier (RFC). Folate uptake primarily occurs at the blood-cerebrospinal fluid barrier (BCSFB) by concerted actions of FRα and PCFT.

View Article and Find Full Text PDF

Hydrocephalus is one of the most common neurological disorders, but pharmacotherapy options are currently lacking due to the complex pathogenesis. The blood-CSF barrier (BCSFB), consisting of choroid plexus (ChP) epithelial cells, is a crucial gate for the entry of peripheral immune cells and its dysfunction emerges as an important contributor to hydrocephalus pathology. Meanwhile, SPAK-mediated CSF hypersecretion in ChP epithelial cells plays an important role in hydrocephalus.

View Article and Find Full Text PDF

Barriers of the central nervous system (CNS), such as the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB), regulate the two-way exchange of material between the blood and CNS. These barriers pose a considerable challenge for efficacious delivery of intravenously administered therapies into the CNS, motivating exploration of their function and ways to modulate their properties. While the BBB and BCSFB can become dysfunctional in patients with chronic CNS diseases, few studies have focused on strategies for targeting these interfaces.

View Article and Find Full Text PDF
Article Synopsis
  • The choroid plexus (CP) and blood-cerebrospinal fluid-barrier (BCSFB) play a critical role in producing and clearing cerebrospinal fluid, and their dysfunction is linked to neurodegenerative diseases like Alzheimer's disease (AD).
  • This study utilized advanced MRI techniques to measure water delivery across the BCSFB in a triple transgenic mouse model of AD, observing significant changes in CP function even before clinical symptoms appear.
  • Results indicated increased BCSFB-mediated water delivery in younger mice, with notable behavioral differences arising around 20 weeks, suggesting that CP changes could serve as early biomarkers for AD.
View Article and Find Full Text PDF